Modern treatment of retinoblastoma: A 2020 review
Retinoblastoma management remains complex, requiring individualized treatment based on International Classification of Retinoblastoma (ICRB) staging, germline mutation status, family psychosocial factors and cultural beliefs, and available institutional resources. For this 2020 retinoblastoma review...
Main Authors: | David Ancona-Lezama, Lauren A Dalvin, Carol L Shields |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2020;volume=68;issue=11;spage=2356;epage=2365;aulast=Ancona-Lezama |
Similar Items
-
Long-term evaluation of outcomes and survival of patients treated for retinoblastoma
by: Krzysztof Morawski, et al.
Published: (2020-06-01) -
Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras
by: David A Camp, et al.
Published: (2019-01-01) -
Outcomes of Advanced Retinoblastoma Treated with Local Salvage Treatment; a Retrospective Case Series.
by: Palwasha Rehman, et al.
Published: (2020-01-01) -
Retinoblastoma in Adults: a Case Report and Literature Review
by: Mehdi Sharifzadeh, et al.
Published: (2014-01-01) -
Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression
by: Irsan E. Kooi, et al.
Published: (2015-07-01)